Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Malaga Cove Capital LLC

Malaga Cove Capital LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,581 shares of the medical equipment provider’s stock after selling 62 shares during the quarter. Malaga Cove Capital LLC’s holdings in Intuitive Surgical were worth $2,251,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Norden Group LLC lifted its holdings in shares of Intuitive Surgical by 32.4% in the 1st quarter. Norden Group LLC now owns 957 shares of the medical equipment provider’s stock worth $382,000 after acquiring an additional 234 shares during the last quarter. Csenge Advisory Group lifted its stake in Intuitive Surgical by 16.4% during the first quarter. Csenge Advisory Group now owns 1,229 shares of the medical equipment provider’s stock worth $490,000 after purchasing an additional 173 shares in the last quarter. Advisory Alpha LLC purchased a new position in shares of Intuitive Surgical during the first quarter worth $414,000. Empirical Finance LLC boosted its position in shares of Intuitive Surgical by 3.5% during the first quarter. Empirical Finance LLC now owns 12,648 shares of the medical equipment provider’s stock worth $5,048,000 after buying an additional 433 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its stake in shares of Intuitive Surgical by 16.1% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 42,804 shares of the medical equipment provider’s stock valued at $17,083,000 after buying an additional 5,941 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock worth $33,839,308. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Up 0.1 %

ISRG stock opened at $515.55 on Thursday. The stock has a market cap of $183.63 billion, a price-to-earnings ratio of 82.89, a PEG ratio of 4.99 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $269.49 and a fifty-two week high of $525.00. The business has a 50 day moving average price of $492.30 and a 200 day moving average price of $450.05.

Analysts Set New Price Targets

A number of equities analysts recently commented on ISRG shares. Wells Fargo & Company raised their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Barclays increased their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Finally, Citigroup boosted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.